Orthofix Procedure Volume Down -60% in April Due to COVID-19

Orthofix reported 1Q20 orthopedic revenue of USD $104.8 million, -3.9% vs. 1Q19. Through January and February, the company was on pace to exceed revenue expectations for the year as late-2019 initiatives began to take hold. Orthofix’s spine segment benefitted from $2.9 million in sales of the M6 cervical disc, an increase of 85% vs. the prior...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us